Long-term effectiveness of vitrectomy in diabetic cystoid macular edema

详细信息    查看全文

• 作者：Javier Navarrete-Sanchis…
• 关键词：Vitrectomy ; Macular edema ; Diabetic retinopathy ; Retina
• 刊名：Graefe's Archive for Clinical and Experimental Ophthalmology
• 出版年：2015
• 出版时间：May 2015
• 年：2015
• 卷：253
• 期：5
• 页码：713-719
• 全文大小：227 KB
• 参考文献：1.Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 91(12):1464-474View Article PubMed
  2.Sander B, Larsen M, Moldow B, Lund-Andersen H (2001) Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. Invest Ophthalmol Vis Sci 42(2):433-38PubMed
  3.Caldwell RB, Slapnick SM, McLaughlin BJ (1985) Lanthanum and freeze-fracture studies of retinal pigment epithelial cell junctions in the streptozotocin diabetic rat. Curr Eye Res 4(3):215-27View Article PubMed
  4.Tso MO, Cunha-Vaz JG, Shih CY, Jones CW (1980) Clinicopathologic study of blood-retinal barrier in experimental diabetes mellitus. Arch Ophthalmol 98(11):2032-040View Article PubMed
  5.Early Treatment Diabetic Retinopathy Study research group (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103(12):1796-806View Article
  6.Haller JA, Qin H, Apte RS, Beck RR, Bressler NM, Browning DJ, Danis RP, Glassman AR, Googe JM, Kollman C, Lauer AK, Peters MA, Stockman ME (2010) Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 117(6):1087-093 e1083View Article PubMed
  7.Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY (1993) The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 111(6):831-36View Article PubMed
  8.Ferris FL 3rd, Miller KM, Glassman AR, Beck RW (2010) A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical research. Ophthalmology 117(8):1512-516View Article PubMed Central PubMed
  9.Raman R, Rani PK, Kulothungan V, Rachepalle SR, Kumaramanickavel G, Sharma T (2010) Influence of serum lipids on clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13. Ophthalmology 117(4):766-72View Article PubMed
  10.Flaxel CJ, Edwards AR, Aiello LP, Arrigg PG, Beck RW, Bressler NM, Bressler SB, Ferris FL 3rd, Gupta SK, Haller JA, Lazarus HS, Qin H (2010) Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network. Retina 30(9):1488-495View Article PubMed
  11.Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99(5):753-59View Article PubMed
  12.Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE (1996) Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 121(4):405-13View Article PubMed
  13.Pendergast SD, Hassan TS, Williams GA, Cox MS, Margherio RR, Ferrone PJ, Garretson BR, Trese MT (2000) Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 130(2):178-86View Article PubMed
  14.Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier B (2005) Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 140(2):295-01PubMed
  15.Yanyali A, Nohutcu AF, Horozoglu F, Celik E (2005) Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Am J Ophthalmol 139(5):795-01View Article PubMed
  16.Yanyali A, Horozoglu F, Celik E, Nohutcu AF (2007) Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Retina 27(5):557-66View Article PubMed
  17.Stefansson E, Landers MB 3rd (2006) How does vitrectomy affect diabetic macular edema? Am J Ophthalmol 141(5):984, author reply 984-985View Article PubMed
  18.Nguyen QD, Shah SM, Van Anden E, Sung JU, Vitale S, Campochiaro PA (2004) Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci 45(2):617-24View Article PubMed
  19.Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL, 3rd, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117 (6):1064-1077 e1035
  20.Krzystolik MG, Strauber SF, Aiello LP, Beck RW, Berger BB, Bressler NM, Browning DJ, Chambers RB, Danis RP, Davis MD, Glassman AR, Gonzalez VH, Greenberg PB, Gross JG, Kim JE, Kollman C (2007) Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 114(8):1520-525View Article PubMed
  21.Kimura T, Kiryu J, Nishiwaki H, Oh H, Suzuma K, Watanabe D, Kurimoto M, Takagi H (2005) Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema. Retina 25(4):454
• 作者单位：Javier Navarrete-Sanchis (1)
  Julian Zarco-Bosquets (1)
  Juan Miguel Tomas-Torrent (1)
  Teresa Diago (1)
  Leticia Ortega-Evangelio (1)
  
  1. Department of Ophthalmology, Hospital Universitario de La Ribera, Crtra Corbera, Km. 1, 46600, Alzira, Spain
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Ophthalmology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1435-702X

文摘

Background The aim of this study is to assess whether the outcome of pars plana vitrectomy for the treatment of cystoid non-tractional diabetic macular edema is stable and durable. Methods A prospective longitudinal analysis of central macular thickness and visual acuity was performed, using repeated-measures ANOVA, in 22 subjects with cystoid diabetic macular edema. Results Of the patients, 45.5 % met the criteria for surgical success at 6?months (achieving a reduction of central macular thickness of over 20?%, without associated loss of vision and central macular thickness less than 300?μm), of which 70?% remained stable at 1?year. A significant outcome of the intervention was found on central macular thickness (p-lt;-.01), but not on visual acuity (p--.159). This change occurred in the immediate postoperative period to remain stable thereafter. Conclusions Vitreoretinal surgery can be an alternative treatment option in cases that do not respond to other types of treatment provided. Its expected benefit is observed in most cases in the immediate postoperative period, and is usually stable and sustained over 1-year follow-up.